Invesco Nasdaq Biotechnology ETF Rating $36.26 -0.04 (-0.11%) As of 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOptions ChainOwnershipRatings Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.72Holdings in IBBQ have an aggregate rating of Moderate Buy based on 522 analyst ratings issued in the past year covering 25 companies (61.4% of the portfolio).IBBQ Aggregate Price Target$36.26High Prediction$36.26Average Prediction$36.26Low Prediction$36.26Holdings in IBBQ have an aggregate price target of $36.26 and a range of $36.26 to $36.26 covering 25 companies (61.4% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBBQ Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.82%AMGNAmgen$444.12+0.3%4.1894 of 5 stars2.40$380.43 -14.3%30Positive NewsAnalyst Revision8.20%VRTXVertex Pharmaceuticals$557.96+0.2%3.6312 of 5 stars2.96$569.52 2.1%23Positive NewsAnalyst Forecast7.30%GILDGilead Sciences$151.22+1.1%3.8658 of 5 stars2.87$158.04 4.5%30Trending NewsAnalyst UpgradeInsider TradeAnalyst Revision5.63%REGNRegeneron Pharmaceuticals$843.47-1.0%4.0744 of 5 stars2.58$800.36 -5.1%24Trending NewsInsider Trade2.91%RVMDRevolution Medicines$210.87+0.8%2.5196 of 5 stars2.95$200.74 -4.8%22Analyst ForecastInsider TradeAnalyst Revision2.11%BIIBBiogen$224.51+0.8%3.0655 of 5 stars2.58$228.50 1.8%33Trending NewsAnalyst Forecast2.06%ALNYAlnylam Pharmaceuticals$264.50-1.1%4.5944 of 5 stars2.88$386.14 46.0%25Analyst Forecast1.98%ILMNIllumina$221.66+3.9%2.1476 of 5 stars2.39$191.31 -13.7%18Positive NewsAnalyst Forecast1.86%INSMInsmed$126.68+0.0%3.5213 of 5 stars3.00$205.52 62.2%251.77%ROIVRoivant Sciences$34.41+0.7%2.0699 of 5 stars2.85$35.14 2.1%13Insider Trade1.76%RPRXRoyalty Pharma$63.88+1.2%3.7366 of 5 stars3.00$60.86 -4.7%81.71%MRNAModerna$148.87-1.3%1.476 of 5 stars2.08$76.72 -48.5%24Trending NewsAnalyst DowngradeInsider TradeOptions VolumeAnalyst RevisionGap Down1.63%INCYIncyte$128.00-0.6%3.6208 of 5 stars2.56$123.10 -3.8%25Positive NewsAnalyst Forecast1.60%ARGXargenex$1,053.46-0.2%4.1566 of 5 stars2.88$1,158.61 10.0%24Analyst Forecast1.44%UTHRUnited Therapeutics$490.24-0.4%4.7382 of 5 stars2.85$646.00 31.8%13Trending NewsInsider Trade1.43%GHGuardant Health$161.04-1.2%3.0988 of 5 stars2.96$183.78 14.1%25Positive NewsAnalyst ForecastGap Down1.27%VTRSViatris$16.94-0.9%2.5863 of 5 stars2.57$17.50 3.3%71.13%MEDPMedpace$593.39+0.1%3.2165 of 5 stars2.25$595.20 0.3%12Positive NewsInsider Trade1.08%BBIOBridgeBio Pharma$75.41-1.4%3.4103 of 5 stars2.83$101.53 34.6%23Positive NewsAnalyst Forecast1.04%JAZZJazz Pharmaceuticals$247.57+0.8%3.855 of 5 stars3.00$285.44 15.3%18Insider Trade1.03%NBIXNeurocrine Biosciences$158.35+0.4%4.9345 of 5 stars2.88$201.05 27.0%24Positive NewsAnalyst Forecast1.03%ASNDAscendis Pharma A/S$271.12+1.4%4.2391 of 5 stars3.05$310.05 14.4%20News CoverageAnalyst ForecastAnalyst RevisionHigh Trading Volume0.90%BMRNBioMarin Pharmaceutical$66.43-0.8%4.8919 of 5 stars2.74$89.17 34.2%23Analyst Forecast0.86%EXELExelixis$59.13+1.0%2.9024 of 5 stars2.35$50.07 -15.3%20Analyst Upgrade0.82%ARWRArrowhead Pharmaceuticals$86.49+1.3%2.1044 of 5 stars2.62$98.42 13.8%13News CoverageAnalyst Forecast This page (NASDAQ:IBBQ) was last updated on 9/3/2026 by MarketBeat.com Staff. From Our PartnersMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.